Natac Natural Ingredients, S.A. (BME:NAT)
Spain · Delayed Price · Currency is EUR 0.6000
0.00 (0.00%)
Aug 27, 2026, 3:30 PM CET
Natac Natural Ingredients Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Property, Plant & Equipment | 43.78 | 35.67 | 26.28 | 2.06 | 0.87 |
Cash & Equivalents | 1.4 | 0.57 | 1.61 | 8.8 | 0.03 |
Accounts Receivable | 11.14 | 4.33 | 10.15 | 0.41 | 0.65 |
Other Receivables | 1.42 | 4.65 | 2.53 | 0.84 | 0.07 |
Investment In Debt and Equity Securities | 0.06 | 0.15 | 0.12 | 5.79 | 3.75 |
Goodwill | 48.68 | 48.68 | 48.68 | 31.36 | 33.49 |
Other Intangible Assets | 5.07 | 6.74 | 8.21 | 6.26 | 3.25 |
Other Current Assets | 14.9 | 18.81 | 16.19 | 0.52 | 0.77 |
Deferred Long-Term Tax Assets | 2.44 | 1.87 | 0.74 | 1.82 | 1.06 |
Deferred Long-Term Charges | 7.14 | 9.27 | 1.35 | - | - |
Other Long-Term Assets | 4.76 | 4.56 | 12.2 | 1.77 | 0.62 |
Total Assets | 140.8 | 135.31 | 128.08 | 59.64 | 44.56 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Current Portion of Long-Term Debt | 35.6 | 28.51 | 20.45 | 0.42 | 2.6 |
Current Portion of Leases | 0.23 | 0.24 | 0.15 | - | - |
Long-Term Debt | 31.96 | 36.7 | 36.49 | 4.09 | 0.13 |
Long-Term Leases | 0.22 | 0.36 | 0.18 | - | - |
Accounts Payable | 1.32 | 2.52 | 1.58 | 1.36 | 0.5 |
Accrued Expenses | 0.91 | 0.21 | 0.26 | 0.32 | 0.05 |
Current Income Taxes Payable | 2.92 | 1.82 | 0.76 | - | - |
Current Unearned Revenue | 2.87 | 3.22 | 3.16 | 0.23 | 0.2 |
Other Current Liabilities | 6.26 | 6.4 | 5.74 | 0.38 | 0.76 |
Long-Term Unearned Revenue | 8.04 | 9.15 | 10.7 | - | - |
Long-Term Deferred Tax Liabilities | 1.25 | 1.56 | 1.84 | 0.06 | 0 |
Other Long-Term Liabilities | 4.22 | 1.94 | 2.79 | 9.22 | 2.33 |
Total Liabilities | 95.8 | 92.61 | 84.11 | 16.08 | 6.58 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 3.48 | 86.97 | 83.78 | 7.56 | 46 |
Additional Paid-In Capital | - | 55.43 | 55.43 | 1.8 | - |
Retained Earnings | 1.07 | 0.4 | 6.41 | 30.46 | -10.2 |
Treasury Stock | -2.06 | -2.19 | -0.39 | -0.1 | -0 |
Comprehensive Income & Other | 42.51 | -97.91 | -103.8 | 2.43 | 1.88 |
Total Common Equity | 45 | 42.7 | 41.44 | 42.15 | 37.67 |
Minority Interest | - | - | 2.53 | 1.41 | 0.31 |
Shareholders' Equity | 45 | 42.7 | 43.97 | 43.56 | 37.99 |
Total Liabilities & Equity | 140.8 | 135.31 | 128.08 | 59.64 | 44.56 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 68.01 | 65.8 | 57.27 | 4.51 | 2.74 |
Net Cash (Debt) | -66.61 | -65.24 | -55.66 | 4.29 | -2.71 |
Net Cash (Debt) Growth | - | - | - | - | - |
Net Cash Per Share | -0.15 | -0.15 | -0.13 | 0.11 | -0.12 |
Filing Date Shares Outstanding | 431.85 | 431.61 | 418.42 | 37.74 | 23 |
Total Common Shares Outstanding | 431.85 | 431.61 | 418.42 | 37.74 | 23 |
Book Value Per Share | 0.10 | 0.10 | 0.10 | 1.12 | 1.64 |
Tangible Book Value | -8.75 | -12.73 | -15.45 | 4.53 | 0.93 |
Tangible Book Value Per Share | -0.02 | -0.03 | -0.04 | 0.12 | 0.04 |
Land | 2.25 | 2.25 | 2.25 | 1.3 | 0.08 |
Buildings | 12.33 | 12.23 | 7.08 | - | - |
Construction In Progress | 13.57 | 4.05 | 7.71 | - | - |